How is sesamin metabolised in the human liver to show its biological effects?

Bibliography

• Hirose N, Inoue T, Nishihara K, Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res 1991;32(4):629-38
   PubMed Web of Science ®Google Scholar
• Hirata F, Fujita K, Ishikura Y, Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis 1996;122(1):135-6
   PubMed Web of Science ®Google Scholar
• Ogawa H, Sasagawa S, Murakami T, Yoshizumi H. Sesame lignans modulate cholesterol metabolism in the stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl 1995;22(1):S310-12
   PubMedGoogle Scholar
• Kiso Y. Antioxidative roles of sesamin, a functional lignan in sesame seed, and it's effect on lipid- and alcohol-metabolism in the liver: a DNA microarray study. Biofactors 2004;21(1-4):191-6
   PubMed Web of Science ®Google Scholar
• Penalvo JL, Hopia A, Adlercreutz H. Effect of sesamin on serum cholesterol and triglycerides levels in LDL receptor-deficient mice. Eur J Nutr 2006;45(8):439-44
   PubMed Web of Science ®Google Scholar
• Nakano D, Itoh C, Takaoka M, Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin. Biol Pharm Bull 2002;25(9):1247-9
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Kita S, Tanida Y, Antihypertensive effect of sesamin. III. Protection against development and maintenance of hypertension in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull 1998;21(5):469-73
   PubMed Web of Science ®Google Scholar
• Kita S, Matsumura Y, Morimoto S, Antihypertensive effect of sesamin. II. Protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull 1995;18(9):1283-5
   PubMed Web of Science ®Google Scholar
• Miyawaki T, Aono H, Toyoda-Ono Y, Antihypertensive effects of sesamin in humans. J Nutr Sci Vitaminol (Tokyo) 2009;55(1):87-91
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Kita S, Morimoto S, Antihypertensive effect of sesamin. I. Protection against deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull 1995;18(7):1016-19
   PubMed Web of Science ®Google Scholar
• Miyahara Y, Komiya T, Katsuzaki H, Sesamin and episesamin induce apoptosis in human lymphoid leukemia Molt 4B cells. Int J Mol Med 2000;6(1):43-6
   PubMed Web of Science ®Google Scholar
• Hirose N, Doi F, Ueki T, Suppressive effect of sesamin against 7,12-dimethylbenz[a]-anthracene induced rat mammary carcinogenesis. Anticancer Res 1992;12(4):1259-65
   PubMed Web of Science ®Google Scholar
• Akimoto K, Kitagawa Y, Akamatsu T, Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab 1993;37(4):218-24
   PubMed Web of Science ®Google Scholar
• Miyake Y, Fukumoto S, Okada M, Antioxidative catechol lignans converted from sesamin and sesaminol triglucoside by culturing with aspergillus. J Agric Food Chem 2005;53(1):22-7
   PubMed Web of Science ®Google Scholar
• Nakai M, Harada M, Nakahara K, Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem 2003;51(6):1666-70
   PubMed Web of Science ®Google Scholar
• Cermak R, Wolffram S. The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms. Curr Drug Metab 2006;7(7):729-44
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Wickham KA, Schmitz DA, Cho AK. Metabolism of methylenedioxyphenyl compounds by rabbit liver preparations. Participation of different cytochrome P450 isozymes in the demethylenation reaction. Biochem Pharmacol 1991;42(5):1061-7
   PubMed Web of Science ®Google Scholar
• Murray M. Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation. Curr Drug Metab 2000;1(1):67-84
   PubMed Web of Science ®Google Scholar
• Yasuda K, Ikushiro S, Kamakura M, Sequential metabolism of sesamin by cytochrome P450 and Udp-glucuronosyltransferase in human liver. Drug Metab Dispos 2011;39(9):1-8
   PubMedGoogle Scholar
• Liu Z, Saarinen NM, Thompson LU. Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats. J Nutr 2006;136(4):906-12
   PubMed Web of Science ®Google Scholar
• Coulman KD, Liu Z, Hum WQ, Whole sesame seed is as rich a source of mammalian lignan precursors as whole flaxseed. Nutr Cancer 2005;52(2):156-65
   PubMed Web of Science ®Google Scholar
• Penalvo JL, Heinonen SM, Aura AM, Adlercreutz H. Dietary sesamin is converted to enterolactone in humans. J Nutr 2005;135(5):1056-62
   PubMed Web of Science ®Google Scholar
• Moazzami AA, Andersson RE, Kamal-Eldin A. Quantitative NMR analysis of a sesamin catechol metabolite in human urine. J Nutr 2007;137(4):940-4
   PubMed Web of Science ®Google Scholar
• Yasuda K, Ikushiro S, Kamakura M, Metabolism of sesamin by cytochrome P450 in human liver microsomes. Drug Metab Dispos 2010;38(12):2117-23
   PubMed Web of Science ®Google Scholar
• Hamada N, Fujita Y, Tanaka A, Metabolites of sesamin, a major lignan in sesame seeds, induce neuronal differentiation in PC12 cells through activation of ERK1/2 signaling pathway. J Neural Transm 2009;116(7):841-52
   PubMed Web of Science ®Google Scholar
• Nakano D, Kwak CJ, Fujii K, Sesamin metabolites induce an endothelial nitric oxide-dependent vasorelaxation through their antioxidative property-independent mechanisms: possible involvement of the metabolites in the antihypertensive effect of sesamin. J Pharmacol Exp Ther 2006;318(1):328-35
   PubMed Web of Science ®Google Scholar
• Pianjing P, Thiantanawat A, Rangkadilok N, Estrogenic activities of sesame lignans and their metabolites on human breast cancer cells. J Agric Food Chem 2011;59(1):212-21
   PubMed Web of Science ®Google Scholar
• Feng J, Shi Z, Ye Z. Effects of metabolites of the lignans enterolactone and enterodiol on osteoblastic differentiation of MG-63 cells. Biol Pharm Bull 2008;31(6):1067-70
   PubMed Web of Science ®Google Scholar
• Umeda-Sawada R, Ogawa M, Igarashi O. The metabolism and distribution of sesame lignans (sesamin and episesamin) in rats. Lipids 1999;34(6):633-7
   PubMed Web of Science ®Google Scholar
• Kushiro M, Takahashi Y, Ide T. Species differences in the physiological activity of dietary lignan (sesamin and episesamin) in affecting hepatic fatty acid metabolism. Br J Nutr 2004;91(3):377-86
   PubMed Web of Science ®Google Scholar
• Jeng KCG, HouRCW. Sesamin and sesamolin: nature's therapeutic lignans. Curr Enzyme Inhib 2005;1:11-20
   Google Scholar
• Ide T, Kushiro M, Takahashi Y, Sesamin, a sesame lignan, as a potent serum lipid-lowering food component. JARQ 2003;37(3):151-8
   Google Scholar
• Sontag TJ, Parker RS. Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status. J Biol Chem 2002;277(28):25290-6
   PubMed Web of Science ®Google Scholar
• Wu JH, Hodgson JM, Clarke MW, Inhibition of 20-hydroxyeicosatetraenoic acid synthesis using specific plant lignans: in vitro and human studies. Hypertension 2009;54(5):1151-8
   PubMed Web of Science ®Google Scholar
• Ikeda S, Tohyama T, Yamashita K. Dietary sesame seed and its lignans inhibit 2,7,8-trimethyl- 2(2'-carboxyethyl)-6-hydroxychroman excretion into urine of rats fed gamma-tocopherol. J Nutr 2002;132(5):961-6
   PubMed Web of Science ®Google Scholar
• Yamashita K, Nohara Y, Katayama K, Namiki M. Sesame seed lignans and gamma-tocopherol act synergistically to produce vitamin E activity in rats. J Nutr 1992;122(12):2440-6
   PubMed Web of Science ®Google Scholar
• Cooney RV, Custer LJ, Okinaka L, Franke AA. Effects of dietary sesame seeds on plasma tocopherol levels. Nutr Cancer 2001;39(1):66-71
   PubMed Web of Science ®Google Scholar
• Shimizu S, Akimoto K, Shinmen Y, Sesamin is a potent and specific inhibitor of delta 5 desaturase in polyunsaturated fatty acid biosynthesis. Lipids 1991;26(7):512-16
   PubMed Web of Science ®Google Scholar
• Ide T, Lim JS, Odbayar TO, Nakashima Y. Comparative study of sesame lignans (sesamin, episesamin and sesamolin) affecting gene expression profile and fatty acid oxidation in rat liver. J Nutr Sci Vitaminol (Tokyo) 2009;55(1):31-43
   PubMed Web of Science ®Google Scholar
• Tsuruoka N, Kidokoro A, Matsumoto I, Modulating effect of sesamin, a functional lignan in sesame seeds, on the transcription levels of lipid- and alcohol-metabolizing enzymes in rat liver: a DNA microarray study. Biosci Biotechnol Biochem 2005;69(1):179-88
   PubMed Web of Science ®Google Scholar
• Nakajima M, Suzuki M, Yamaji R, Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds. Xenobiotica 1999;29(12):1191-202
   PubMed Web of Science ®Google Scholar
• Chatterjee P, Franklin MR. Human cytochrome p450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components. Drug Metab Dispos 2003;31(11):1391-7
   PubMed Web of Science ®Google Scholar
• Usia T, Watabe T, Kadota S, Tezuka Y. Metabolite-cytochrome P450 complex formation by methylenedioxyphenyl lignans of Piper cubeba: mechanism-based inhibition. Life Sci 2005;76(20):2381-91
   PubMed Web of Science ®Google Scholar
• Heydari A, Yeo KR, Lennard MS, Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine. Drug Metab Dispos 2004;32(11):1213-17
   PubMed Web of Science ®Google Scholar
• Subehan S, Kadota S, Tezuka Y. In vitro mechanism-based inactivation of cytochrome P450 3A4 by a new constituent of cinnamomum burmani. Planta Med 2008;74(12):1474-80
   PubMed Web of Science ®Google Scholar
• Yoo HH, Lee SH, Jin C, Kim DH. Mechanism-based inactivation of cytochrome P450 3A4 by methylenedioxyphenyl lignans from Acanthopanax chiisanensis. Planta Med 2008;74(8):822-7
   PubMed Web of Science ®Google Scholar
• Taesotikul T, Dumrongsakulchai W, Wattanachai N, Inhibitory effects of phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Drug Metab Pharmacokinet 2011;26(2):154-61
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W, Guo LQ, Fukuda K, Inhibition selectivity of grapefruit juice components on human cytochromes P450. Arch Biochem Biophys 2000;378(2):356-63
   PubMed Web of Science ®Google Scholar
• Zhou S, Chan E, Lim LY, Therapeutic drugs that behave as mechanism-based inhibitors of cytochrome P450 3A4. Curr Drug Metab 2004;5(5):415-42
   PubMed Web of Science ®Google Scholar
• Kawai Y, Nishikawa T, Shiba Y, Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: implication in the anti-atherosclerotic mechanism of dietary flavonoids. J Biol Chem 2008;283(14):9424-34
   PubMed Web of Science ®Google Scholar
• Paine MF, Widmer WW, Hart HL, A furanocoumarin-free grapefruit juice establishes furanocoumarins as the mediators of the grapefruit juice-felodipine interaction. Am J Clin Nutr 2006;83(5):1097-105
   PubMed Web of Science ®Google Scholar
• Moritani T, Hamada T, Kimura T, Changes in cardiac autonomic activities and antioxidant effects of sesamin during smoking. Med Sci Sports Exerc 2003;35:S269
   Google Scholar